A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study

2024 . Niger, Monica | Nichetti, Federico | Fornaro, Lorenzo | Pircher, Chiara | Morano, Federica | Palermo, Federica | Rimassa, Lorenza | Pressiani, Tiziana | Berardi, Rossana | Gardini, Andrea Casadei | Sperti, Elisa | Salvatore, Lisa | Melisi, Davide | Bergamo, Francesca | Siena, Salvatore | Mosconi, Stefania | Longarini, Raffaella | Arcangeli, Giuseppina | Corallo, Salvatore | Delliponti, Laura | Tamberi, Stefano | Fea, Elena | Brandi, Giovanni | Rapposelli, Ilario Giovanni | Salati, Massimiliano | Baili, Paolo | Miceli, Rosalba | Ljevar, Silva | Cavallo, Ilaria | Sottotetti, Elisa | Martinetti, Antonia | Busset, Michele Droz Dit | Sposito, Carlo | Di Bartolomeo, Maria | Pietrantonio, Filippo | de Braud, Filippo | Mazzaferro, Vincenzo